Skip to Content
You are currently on the new version of our website. Access the old version .
CancersCancers
  • Correction
  • Open Access

17 November 2022

2 Pages

Correction: Lee et al. Tropomyosin-Related Kinase Fusions in Gastrointestinal Stromal Tumors. Cancers 2022, 14, 2659

,
,
,
,
,
,
,
,
…
1
Department of Internal Medicine, Division of Medical Oncology, Eunpyeong St. Mary’s Hospital, The Catholic University of Korea, Seoul 03312, Republic of Korea
2
Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06273, Republic of Korea
3
Department of Internal Medicine, Division of Hospital Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea
4
Department of Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea
In the original article [1], there was a mistake in Table 1 as published. There were two tumors with tumor size ≤ 5 cm in the NTRK fusion group (n = 5); however, there were three tumors with tumor size ≤ 5 cm in the five cases in Table 3. Moreover, patients 0 and 1 were low- and intermediate-risk of metastasis, respectively, in Table 1, which was not consistent with the results in Table 3. The corrected Table 1 appears below. Modified numbers are red-colored.
Table 1. Baseline characteristics.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original publication has also been updated.

Reference

  1. Lee, J.H.; Shin, S.-J.; Choe, E.-A.; Kim, J.; Hyung, W.J.; Kim, H.S.; Jung, M.; Beom, S.-H.; Kim, T.I.; Ahn, J.B.; et al. Tropomyosin-related kinase fusions in gastrointestinal stromal tumors. Cancers 2022, 14, 2659. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.